Cytokinetics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. 

CEO
Robert I. Blum
CEORobert I. Blum
Employees
253
Employees253
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
1997
Founded1997
Employees
253
Employees253

CYTK Key Statistics

Market cap
3.51B
Market cap3.51B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
992.77K
Average volume992.77K
High today
$37.61
High today$37.61
Low today
$36.67
Low today$36.67
Open price
$36.86
Open price$36.86
Volume
1.26M
Volume1.26M
52 Week high
$55.80
52 Week high$55.80
52 Week low
$29.26
52 Week low$29.26

CYTK News

Yahoo Finance 21h
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136 - Yahoo Finance

Cytokinetics, Incorporated Advancement of Novel Cardiac Troponin Activator Expands Cardiovascular Franchise for Conditions Associated with Impaired Cardiac Con...

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136 - Yahoo Finance
Yahoo Finance 7d
Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND - Yahoo Finance

Cytokinetics, Incorporated SOUTH SAN FRANCISCO, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced one poster...

Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND - Yahoo Finance

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

CYTK Earnings

-$1.52
-$1.01
-$0.51
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, After Hours
ActualExpected Feb 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.